Related Experiment Video
Updated: May 21, 2026
04:33
Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
Heightened cough response to bronchoconstriction in cough variant asthma
Noriyuki Ohkura1, Masaki Fujimura, Yusuke Nakade
1Respiratory Medicine, Kanazawa University Hospital, Ishikawa, Japan.
Respirology (Carlton, Vic.)
|June 8, 2012
Summary
Cough variant asthma (CVA) patients exhibit a heightened cough response to bronchoconstriction compared to normal controls. This increased cough sensitivity to airway narrowing is a key characteristic of CVA.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Investigation
Background:
- The underlying mechanisms of cough variant asthma (CVA) remain incompletely understood.
- Investigating the relationship between bronchoconstriction and cough in CVA is crucial for diagnosis and management.
Purpose of the Study:
- To compare the cough response to induced bronchoconstriction in patients with CVA and healthy individuals.
- To evaluate the effect of therapy on cough response in CVA patients.
Main Methods:
- Bronchial responsiveness to methacholine (MCh) was assessed in CVA patients and normal controls (NC).
- Cough frequency was measured following induced bronchoconstriction using methacholine challenges.
- Bronchoconstriction was quantified by changes in partial expiratory flow-volume curves (PEF40) and FEV1.
Main Results:
- CVA patients demonstrated a significantly higher number of coughs in response to both mild (PC35-PEF40) and severe (PC20-FEV1) bronchoconstriction compared to NC subjects (P < 0.05).
- Following therapy, CVA patients showed a significant reduction in cough frequency at both PC35-PEF40 and PC20-FEV1 levels (P < 0.05).
Conclusions:
- Heightened cough response to bronchoconstriction is a defining feature of cough variant asthma.
- Therapeutic interventions can effectively reduce cough hypersensitivity in CVA patients.
Related Concept Videos
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.